Cencora, Inc. (COR) is a publicly traded Healthcare sector company. As of July 9, 2026, COR trades at $307.11 with a market cap of $59.24B and a P/E ratio of 149.65. COR moved +1.67% today. Year to date, COR is -8.34%; over the trailing twelve months it is +3.87%. Its 52-week range spans $223.92 to $377.54. Analyst consensus is strong buy with an average price target of $353.63. Rallies surfaces COR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cardinal Health Shares Jump 1.3% on Healthcare Distributor Buyback Trends: Cardinal Health shares rose 1.32% after a report highlighted McKesson’s ongoing share repurchase program that has trimmed its outstanding share count, emphasizing intensifying buyback activity in the healthcare distribution sector. The analysis suggests such aggressive repurchases are reshaping valuation dynamics among distributors.
| Metric | Value |
|---|---|
| Price | $307.11 |
| Market Cap | $59.24B |
| P/E Ratio | 149.65 |
| EPS | $2.06 |
| Dividend Yield | 0.60% |
| 52-Week High | $377.54 |
| 52-Week Low | $223.92 |
| Volume | 1.82M |
| Avg Volume | 0 |
| Revenue (TTM) | $638.56M |
| Net Income | $99.92M |
| Gross Margin | 0.00% |
10 analysts cover COR: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $353.63.